MetLife Investment Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $117K | Buy |
|
|||||
|
2024
Q4 | $81K | Sell |
|
|||||
|
2024
Q3 | $149K | Sell |
|
|||||
|
2024
Q2 | $138K | Buy |
|
|||||
|
2024
Q1 | $219K | Buy |
|
|||||
|
2023
Q4 | $135K | Hold |
|
|||||
|
2023
Q3 | $133K | Hold |
|
|||||
|
2023
Q2 | $209K | Hold |
|
|||||
|
2023
Q1 | $208K | Hold |
|
|||||
|
2022
Q4 | $264K | Hold |
|
|||||
|
2022
Q3 | $454K | Buy |
|
|||||
|
2022
Q2 | $460K | Buy |
|
|||||
|
2022
Q1 | $331K | Buy |
|
|||||
|
2021
Q4 | $342K | Hold |
|
|||||
|
2021
Q3 | $589K | Hold |
|
|||||
|
2021
Q2 | $597K | Hold |
|
|||||
|
2021
Q1 | $809K | Hold |
|
|||||
|
2020
Q4 | $578K | Hold |
|
|||||
|
2020
Q3 | $864K | Buy |
|
|||||
|
2020
Q2 | $923K | Buy |
|
|||||
|
2020
Q1 | $350K | Hold |
|
|||||
|
2019
Q4 | $468K | Hold |
|
|||||
|
2019
Q3 | $491K | Hold |
|
|||||
|
2019
Q2 | $484K | Buy |
|
|||||
|
2019
Q1 | $365K | Hold |
|
|||||
|
2018
Q4 | $340K | Buy |
|